[ 11 ] that showed increased risk of CVE with aromatase inhibitor compared to placebo with borderline significance.
← all excerpts
Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data.
1
—
—